MicroConstants China completed a TQT study for a new drug registration in China

MicroConstants China completed a TQT study for a new drug registration in China 

previous：MicroConstants China PK lab passed 4th OECD GLP inspection
next：Liver Cancer Drug Candidate PTX-9908 Received Taiwan FDA IND Approval